Laura Shawver
CIK 1551891 · Chief Executive Officer · last filed 2026-06-26
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$2.21M
Companies
6
Total Filings
47
Lifetime Open-Market Net
-$8.63M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SPRY | Director | 260,348 | $5.67 | $1.48M | -$8.63M | 16 | 2026-06-26 |
| RLAY | Director | 40,000 | $18.29 | $731.6K | $0 | 5 | 2024-06-05 |
| ARS Pharmaceuticals, Inc. (SBTX) Delisted | Chief Executive Officer | 254,242 | $5.87 | $1.49M | $0 | 4 | 2022-08-09 |
| NKTX | Director | — | $2.22 | — | $0 | 3 | 2022-06-10 |
| Synthorx, Inc. (THOR) Delisted | President and CEO | 215,595 | — | — | $0 | 5 | 2020-01-24 |
| CORNERSTONE THERAPEUTICS INC (CRTX) Delisted | Director | — | $1.95 | — | $0 | 3 | 2014-02-04 |
Recent Filings · Page 2 of 5
47 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-12-09 | SPRY | Notice (144/A) | −200,000 | -$2.71M | EDGAR |
| 2024-12-04 | SPRY | Mixed | — | -$2.29M | EDGAR |
| 2024-12-02 | SPRY | Notice (144) | −200,000 | -$2.71M | EDGAR |
| 2024-06-24 | SPRY | Grant (A) | — | $0 | EDGAR |
| 2024-06-05 | RLAY | Grant (A) | — | $0 | EDGAR |
| 2023-09-05 | SPRY | Mixed | — | -$643.5K | EDGAR |
| 2023-09-01 | SPRY | Notice (144) | −100,000 | -$770.5K | EDGAR |
| 2023-08-07 | SPRY | Mixed | — | -$259.3K | EDGAR |
| 2023-08-03 | SPRY | Mixed | — | -$322.0K | EDGAR |
| 2023-08-01 | SPRY | Notice (144) | −100,000 | -$720.0K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.